Great Multiple Myeloma links shared by Doctor Contributors

Oncology Medical Article | Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma

mdlinx.com — “Oncology Medical Article: Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma” View full resource at mdlinx.com

Most Recently Shared on March 13, 2012 at 9:22 am By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma... http://t.co/EUGSk1gi #oncology

2 months ago...

Bone marrow cancer gene clues found - Health News - NHS Choices

nhs.uk — “A gene defect increases the risk of a type of bone marrow cancer by 30%, the Daily Mail reported. The news is based on an examination of people with multiple myeloma, a relatively rare type of cancer that starts...” View full resource at nhs.uk

Most Recently Shared on November 30, 2011 at 12:31 am By:

Catherine Saxelby - Foodwatch Dietitian and Nutritionist

New from NHS: Bone marrow cancer gene clues found - A gene defect increases the risk of a type of bone marrow cancer... http://t.co/0PHaltRN

6 months ago...

Nice review of neuropathy associated with #MGUS highlighting the need for more studies and new treatment options : http://t.co/zCDoBF9N.

t.co — “Nice review of neuropathy associated with #MGUS highlighting the need for more studies and new treatment options : http://t.co/zCDoBF9N.” View full resource at t.co

Most Recently Shared on November 27, 2011 at 3:26 pm By:

Robert Z. Orlowski Physician, Doctor, and Internist

Nice review of neuropathy associated with #MGUS highlighting the need for more studies and new treatment options : http://t.co/zCDoBF9N.

6 months ago...

Nice review of the current status of monoclonal antibody-based therapies for multiple #myeloma : http://t.co/wauvb2iE.

t.co — “Nice review of the current status of monoclonal antibody-based therapies for multiple #myeloma : http://t.co/wauvb2iE.” View full resource at t.co

Most Recently Shared on November 6, 2011 at 1:49 pm By:

Robert Z. Orlowski Physician, Doctor, and Internist

Nice review of the current status of monoclonal antibody-based therapies for multiple #myeloma : http://t.co/wauvb2iE.

7 months ago...

Oncology Article | A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

mdlinx.com — “A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients” View full resource at mdlinx.com

Most Recently Shared on September 29, 2011 at 2:05 pm By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective... http://t.co/Q0GK8wmR #oncology

Onyx Pharmaceuticals Submits New Drug Application for Carfilzomib in Relapsed and Refractory Multiple Myeloma

bioportfolio.com — “Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has completed the New Drug Application (NDA) submission to the U.S. Food and Drug...” View full resource at bioportfolio.com

Most Recently Shared on September 28, 2011 at 3:27 pm By:

Thomas J Reid MD PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist

Myeloma - new drug (carfilzomib) sent to FDA. #myeloma #relapse #refractory #carfilzomib #proteasome #inhibitor http://t.co/9pMpqNip

Neurology Article | multiple myeloma

mdlinx.com — “Extramedullary intracranial localization of multiple myeloma and treatment with novel agents” View full resource at mdlinx.com

Most Recently Shared on September 9, 2011 at 7:27 pm By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: Cancer http://t.co/QUnqLsY #neuro

PhysOrg Health News Health News

Researchers use new tool to counter multiple myeloma drug resistance

medicalxpress.com — “Moffitt Cancer Center researchers, and colleagues, are pioneering promising research utilizing a monitoring technology that could provide a better understanding of acquired drug resistance and assist in clinical decision-making for developing individualized patient treatments for multiple myeloma.” View full resource at medicalxpress.com

Most Recently Shared on September 9, 2011 at 6:44 pm By:

Researchers use new tool to counter multiple myeloma drug resistance http://t.co/L50sAw9

PhysOrg Health News Health News

Novel approach scores first success against elusive cancer gene

medicalxpress.com — “Dana-Farber Cancer Institute scientists have successfully disrupted the function of a cancer gene involved in the formation of most human tumors by tampering with the gene's 'on' switch and growth signals, rather than targeting the gene itself. The results, achieved in multiple myeloma cells, offer ...” View full resource at medicalxpress.com

Most Recently Shared on September 9, 2011 at 2:56 pm By:

Novel approach scores first success against elusive cancer gene http://t.co/i3lJg1t

Oncology Article | Multiple Myeloma

mdlinx.com — “Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach” View full resource at mdlinx.com

Most Recently Shared on September 9, 2011 at 8:56 am By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Tre... http://t.co/HBXwAdx #oncology

Oncology Article | multiple myeloma

mdlinx.com — “Extramedullary intracranial localization of multiple myeloma and treatment with novel agents” View full resource at mdlinx.com

Most Recently Shared on September 8, 2011 at 2:36 pm By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: Cancer http://t.co/tpe9Wxg #oncology

Oncology Article | multiple myeloma

mdlinx.com — “18F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: A systematic review” View full resource at mdlinx.com

Most Recently Shared on September 6, 2011 at 12:54 pm By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

18F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: A ... http://t.co/48I2ypp #oncology

9 months ago...